Health

Health funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.

MRFF – 2026 Consumer-Led Research Grant Opportunity (GO8270)

NHMRC’s GO8270 supports consumer-led medical research partnerships through two streams: short incubator pilots and scalable targeted calls focused on cancer, long-term conditions, and mental health.

Status: Open Type: Grant Amount: up to $20,000,000 total; up to $2,500,000 per grant Deadline: Aug 5, 2026 Location: Australia

New Jersey Temporary Disability Benefits: How to Get Up to 85 Percent Pay Replacement (Max $1,055 Weekly) for Up to 26 Weeks

Getting sick is stressful. Getting sick while your paycheck evaporates is a different kind of stress—like trying to patch a leaky roof during a thunderstorm with a single paper towel.

Status: Rolling Type: Funding Opportunity Amount: 85% of average weekly wage up to $1,055 for 26 weeks Deadline: Rolling or ongoing Location: New Jersey

NIH Mentored Patient-Oriented Research Career Development Award (K23)

Mentored NIH career development award for clinically trained investigators building a patient-oriented research career.

Status: Open Type: Grant Amount: Salary support up to $100,000 plus fringe and up to $50,000 in research support per year … Deadline: Jun 12, 2026 Location: United States

NIH PA-26-001: Administrative Supplements to Existing NIH Grants and Cooperative Agreements

NIH’s PA-26-001 is an open parent supplement program for current NIH-funded investigators that supports additional funding within the scope of an active award when unforeseen costs or opportunities require short-notice budget additions.

Status: Open Type: Grant Deadline: Nov 30, 2028 Location: United States and NIH partner countries via non-subaward foreign components

NIH SBIR/STTR Omnibus Solicitation

NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) opportunities for early-stage biomedical commercialization.

Status: Deadline Unknown Type: Grant Amount: Phase I up to $300,000; Phase II up to $2 million (budget waivers available) Deadline: September 5, January 5, and April 5 (moved to the next business day if on a weekend or Federal holiday) Location: United States

PAR-27-015: Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All

A NIH phased cooperative agreement (UG3/UH3) to fund community-partnered interventions that improve oral health through cross-sector data and practice transformation in US communities.

Status: Open Type: Grant Amount: Up to $300,000 per year for UG3 (2 years) and up to $650,000 per year for UH3 (5 years) Deadline: Oct 16, 2026 Location: United States

Research Project Grant (R01) | NIH

NIH R01 overview with current standard due-date cycles, registration requirements, and application workflow guidance.

Status: Open Type: Grant Amount: Varies by institute and FOA Deadline: Jun 5, 2026 Location: United States and Global (institution and FOA dependent)

RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.

Status: Open Type: Grant Amount: $74,500,000 total program funding in the FY2027 notice, with up to 7 awards Deadline: Sep 18, 2026 Location: United States

RFA-HL-26-012: NIH StARR (R38) 2026-2027 Funding for Residency Research Programs

NIH StARR (R38) supports residency programs that give postdoctoral-level clinicians mentored research time and a path toward clinician-investigator careers.

Status: Open Type: Grant Deadline: Oct 13, 2026 Location: United States

RFA-HL-26-017: NIH Catalyze Product Definition for Small Molecules and Biologics (R61/R33)

NIH's RFA-HL-26-017 supports early-stage translational projects that generate and validate therapeutic candidates for HLBS diseases through a phased R61/R33 development pathway.

Status: Rolling Type: Grant Amount: Up to $400,000 direct costs per year in the R61 phase and up to $400,000 direct costs per year … Deadline: Rolling or ongoing Location: United States